-
Acrolein enhances epigenetic modifications, FasL expression and hepatocyte toxicity induced by anti-HIV drug Zidovudine.
Toxicology in vitro : an international journal published in association with BIBRA 20160901
-
Diesel exhaust induced pulmonary and cardiovascular impairment: the role of hypertension intervention.
Toxicology and applied pharmacology 20130415
-
Cardiovascular disease is associated with high-fat-diet-induced liver damage and up-regulation of the hepatic expression of hypoxia-inducible factor 1α in a rat model.
Clinical science (London, England : 1979) 20130101
-
Synthesis, characterization, biological activity and equilibrium studies of metal(II) ion complexes with tridentate hydrazone ligand derived from hydralazine.
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20121201
-
Chaperone heat shock protein 90 mobilization and hydralazine cytoprotection against acrolein-induced carbonyl stress.
Molecular pharmacology 20121101
-
Iron chelation inhibits the development of pulmonary vascular remodeling.
Free radical biology & medicine 20121101
-
Regulation of vascular tone and pulse wave velocity in human muscular conduit arteries: selective effects of nitric oxide donors to dilate muscular arteries relative to resistance vessels.
Hypertension (Dallas, Tex. : 1979) 20121101
-
Selective PDE5A inhibition with sildenafil rescues left ventricular dysfunction, inflammatory immune response and cardiac remodeling in angiotensin II-induced heart failure in vivo.
Basic research in cardiology 20121101
-
Favorable effects of vasodilators on left ventricular remodeling in asymptomatic patients with chronic moderate-severe aortic regurgitation and normal ejection fraction: a meta-analysis of clinical trials.
Clinical cardiology 20121001
-
Sympathoinhibition caused by orally administered telmisartan through inhibition of the AT₁ receptor in the rostral ventrolateral medulla of hypertensive rats.
Hypertension research : official journal of the Japanese Society of Hypertension 20120901
-
Effect of fixed-dose combined isosorbide dinitrate/hydralazine in elderly patients in the African-American heart failure trial.
Journal of cardiac failure 20120801
-
Enhanced intrarenal receptor-mediated prorenin activation in chronic progressive anti-thymocyte serum nephritis rats on high salt intake.
American journal of physiology. Renal physiology 20120701
-
Hydralazine as a selective probe inactivator of aldehyde oxidase in human hepatocytes: estimation of the contribution of aldehyde oxidase to metabolic clearance.
Drug metabolism and disposition: the biological fate of chemicals 20120701
-
Valproic acid cooperates with hydralazine to augment the susceptibility of human osteosarcoma cells to Fas- and NK cell-mediated cell death.
International journal of oncology 20120701
-
Natriuretic peptide receptor guanylyl cyclase-A protects podocytes from aldosterone-induced glomerular injury.
Journal of the American Society of Nephrology : JASN 20120701
-
Epigenetic therapy with hydralazine and magnesium valproate reverses imatinib resistance in patients with chronic myeloid leukemia.
Clinical lymphoma, myeloma & leukemia 20120601
-
Treatment of nuclear-donor cells or cloned zygotes with chromatin-modifying agents increases histone acetylation but does not improve full-term development of cloned cattle.
Cellular reprogramming 20120601
-
Posterior reversible encephalopathy syndrome.
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 20120601
-
Vaccination against the angiotensin type 1 receptor for the prevention of L-NAME-induced nephropathy.
Hypertension research : official journal of the Japanese Society of Hypertension 20120501
-
Early treatment with olmesartan prevents juxtamedullary glomerular podocyte injury and the onset of microalbuminuria in type 2 diabetic rats.
American journal of hypertension 20120501
-
A race-based detour to personalized medicine.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20120417
-
Aldosterone does not contribute to renal p21 expression during the development of angiotensin II-induced hypertension in mice.
American journal of hypertension 20120301
-
Characterization of aldehyde oxidase enzyme activity in cryopreserved human hepatocytes.
Drug metabolism and disposition: the biological fate of chemicals 20120201
-
Novel mechanism of angiotensin II-induced cardiac injury in hypertensive rats: the critical role of ASK1 and VEGF.
Hypertension research : official journal of the Japanese Society of Hypertension 20120201
-
Hydralazine-induced lupus erythematosis.
Journal of clinical hypertension (Greenwich, Conn.) 20120201
-
The short life of a race drug.
Lancet (London, England) 20120114
-
Evaluation of teratogenic effects of risperidone following simultaneous administration with antihypertensive and antiemetic drugs.
Pakistan journal of pharmaceutical sciences 20120101
-
DNA methylation-independent reversion of gemcitabine resistance by hydralazine in cervical cancer cells.
PloS one 20120101
-
DNMT (DNA methyltransferase) inhibitors radiosensitize human cancer cells by suppressing DNA repair activity.
Radiation oncology (London, England) 20120101
-
Attenuation of mouse somatic and emotional inflammatory pain by hydralazine through scavenging acrolein and inhibiting neuronal activation.
Pain physician 20120101
-
Letter by Taylor et al regarding article, 'Hydralazine and isosorbide dinitrate in heart failure: historical perspectives, mechanisms, and future directions'.
Circulation 20111206
-
A double-blind, placebo-controlled, randomized phase III trial of chemotherapy plus epigenetic therapy with hydralazine valproate for advanced cervical cancer. Preliminary results.
Medical oncology (Northwood, London, England) 20111201
-
Upregulation of NKG2D ligands and enhanced natural killer cell cytotoxicity by hydralazine and valproate.
International journal of oncology 20111201
-
Combination of thiazolidinedione and hydralazine suppresses proliferation and induces apoptosis by PPARγ up-expression in MDA-MB-231 cells.
Experimental and molecular pathology 20111201
-
Committee Opinion no. 514: emergent therapy for acute-onset, severe hypertension with preeclampsia or eclampsia.
Obstetrics and gynecology 20111201
-
Natural history of end-stage LV dysfunction: has it improved from the classic Franciosa and Cohn Graph?
Cardiology clinics 20111101
-
Rationale and design of the Newer Versus Older Antihypertensive Agents in African Hypertensive Patients (NOAAH) trial.
Blood pressure 20111001
-
Scalable synthesis of 1-bicyclo[1.1.1]pentylamine via a hydrohydrazination reaction.
Organic letters 20110902
-
Acrolein scavengers: reactivity, mechanism and impact on health.
Molecular nutrition & food research 20110901
-
Hydralazine-induced promoter demethylation enhances sarcoplasmic reticulum Ca2+ -ATPase and calcium homeostasis in cardiac myocytes.
Laboratory investigation; a journal of technical methods and pathology 20110901
-
Older blood pressure medications-do they still have a place?
The American journal of cardiology 20110715
-
Atrial fibrillation and mortality in African American patients with heart failure: results from the African American Heart Failure Trial (A-HeFT).
American heart journal 20110701
-
Antiatherogenic effect of bisvanillyl-hydralazone, a new hydralazine derivative with antioxidant, carbonyl scavenger, and antiapoptotic properties.
Antioxidants & redox signaling 20110601
-
Hydralazine and isosorbide dinitrate in heart failure: historical perspective, mechanisms, and future directions.
Circulation 20110531
-
Temporary treatment with AT1 receptor blocker, valsartan, from early stage of hypertension prevented vascular remodeling.
American journal of hypertension 20110501
-
Angiotensin-(1-7) blockade attenuates captopril- or hydralazine-induced cardiovascular protection in spontaneously hypertensive rats treated with NG-nitro-L-arginine methyl ester.
Journal of cardiovascular pharmacology 20110501
-
A tale of two rashes.
The American journal of medicine 20110501
-
Postpartum preeclampsia: emergency department presentation and management.
The Journal of emergency medicine 20110401
-
Hydralazine and magnesium valproate as epigenetic treatment for myelodysplastic syndrome. Preliminary results of a phase-II trial.
Annals of hematology 20110401
-
Antihypertensive therapy increases tetrahydrobiopterin levels and NO/cGMP signaling in small arteries of angiotensin II-infused hypertensive rats.
American journal of physiology. Heart and circulatory physiology 20110301
-
Tetrahydrobiopterin and hypertension: more than an emigrating story.
American journal of physiology. Heart and circulatory physiology 20110301
-
Estrogen receptor-beta signals left ventricular hypertrophy sex differences in normotensive deoxycorticosterone acetate-salt mice.
Hypertension (Dallas, Tex. : 1979) 20110301
-
Inhibition of semicarbazide-sensitive amine oxidase attenuates myocardial ischemia-reperfusion injury in an in vivo rat model.
Life sciences 20110214
-
Changes in angiotensin receptors expression play a pivotal role in the renal damage observed in spontaneously hypertensive rats.
American journal of physiology. Renal physiology 20110201
-
Transcriptional changes induced by epigenetic therapy with hydralazine and magnesium valproate in cervical carcinoma.
Oncology reports 20110201
-
Aldosterone/Mineralocorticoid receptor stimulation induces cellular senescence in the kidney.
Endocrinology 20110201
-
Question: does isosorbide dinitrate/hydralazine therapy benefit systolic heart failure patients with renal insufficiency?
The Journal of the Oklahoma State Medical Association 20110201
-
Anti-acrolein treatment improves behavioral outcome and alleviates myelin damage in experimental autoimmune encephalomyelitis mouse.
Neuroscience 20110126
-
Identification of clinically used drugs that activate pregnane X receptors.
Drug metabolism and disposition: the biological fate of chemicals 20110101
-
Bradykinin B2 receptor-dependent enhancement of enalapril-evoked hypotension in ethanol-fed female rats.
Journal of cardiovascular pharmacology 20110101
-
Combretastatin-induced hypertension and the consequences for its combination with other therapies.
Vascular pharmacology 20110101
-
Changes in fetal and maternal Doppler parameters observed during acute severe hypertension treatment with hydralazine or labetalol: a randomized controlled trial.
Ultrasound in medicine & biology 20110101
-
Grassroots marketing in a global era: more lessons from BiDil.
The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics 20110101
-
Iterative CT reconstruction of aortic intramural hematoma.
Circulation journal : official journal of the Japanese Circulation Society 20110101
-
Comparison of the efficacy of nifedipine and hydralazine in hypertensive crisis in pregnancy.
Acta medica Iranica 20110101
-
Antihypertensive treatment differentially affects vascular sphingolipid biology in spontaneously hypertensive rats.
PloS one 20110101
-
Hydralazine modifies Aβ fibril formation and prevents modification by lipids in vitro.
Biochemistry 20101214
-
Angiotensin II overcomes strain-dependent resistance of rapid CKD progression in a new remnant kidney mouse model.
Kidney international 20101201
-
Connective tissue growth factor induction in a pressure-overloaded heart ameliorated by the angiotensin II type 1 receptor blocker olmesartan.
Hypertension research : official journal of the Japanese Society of Hypertension 20101201
-
Drug-induced lupus: an update.
Autoimmunity reviews 20101101
-
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Bioorganic & medicinal chemistry letters 20101101
-
Mineralocorticoid receptor activation contributes to salt-induced hypertension and renal injury in prepubertal Dahl salt-sensitive rats.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20100901
-
HDAC inhibition attenuates inflammatory, hypertrophic, and hypertensive responses in spontaneously hypertensive rats.
Hypertension (Dallas, Tex. : 1979) 20100901
-
Hydralazine for essential hypertension.
The Cochrane database of systematic reviews 20100804
-
Central and peripheral mechanisms of T-lymphocyte activation and vascular inflammation produced by angiotensin II-induced hypertension.
Circulation research 20100723
-
Primary care physicians' attitudes regarding race-based therapies.
Journal of general internal medicine 20100501
-
Losartan increases NO release in afferent arterioles during regression of L-NAME-induced renal damage.
American journal of physiology. Renal physiology 20100501
-
Clinical pearls in cardiology.
Mayo Clinic proceedings 20100501
-
Platinum-catalyzed intramolecular hydrohydrazination: evidence for alkene insertion into a Pt-N bond.
Journal of the American Chemical Society 20100414
-
Hydralazine does not ameliorate nitric oxide resistance in chronic heart failure.
Cardiovascular drugs and therapy 20100401
-
Effect of olmesartan and pravastatin on experimental cerebral aneurysms in rats.
Brain research 20100331
-
High-salt diet increases plasma adiponectin levels independent of blood pressure in hypertensive rats: the role of the renin-angiotensin-aldosterone system.
Journal of hypertension 20100101
-
Aliskiren prevents cardiovascular complications and pancreatic injury in a mouse model of obesity and type 2 diabetes.
Diabetologia 20100101
-
Racial differences in heart failure therapeutics.
Heart failure clinics 20100101
-
Role of angiotensin II in the remodeling induced by a chronic increase in flow in rat mesenteric resistance arteries.
Hypertension (Dallas, Tex. : 1979) 20100101
-
Treatment of hypertension in the inpatient setting: use of intravenous labetalol and hydralazine.
Journal of clinical hypertension (Greenwich, Conn.) 20100101
-
Epigenetic therapy and cisplatin chemoradiation in FIGO stage IIIB cervical cancer.
European journal of gynaecological oncology 20100101
-
Hypoxic pre-conditioning in a rat renal ischemia model: an evaluation of the use of hydralazine.
World journal of urology 20091201
-
Olmesartan reduces oxidative stress in the brain of stroke-prone spontaneously hypertensive rats assessed by an in vivo ESR method.
Hypertension research : official journal of the Japanese Society of Hypertension 20091201
-
Acrolein scavenging: a potential novel mechanism of attenuating oxidative stress following spinal cord injury.
Journal of neurochemistry 20091201
-
Dysfunctional corin i555(p568) allele is associated with impaired brain natriuretic peptide processing and adverse outcomes in blacks with systolic heart failure: results from the Genetic Risk Assessment in Heart Failure substudy.
Circulation. Heart failure 20091101
-
Symptomatic and hemodynamic benefit of pentaerythrityl tetranitrate and hydralazine in a case of congestive heart failure.
Clinical research in cardiology : official journal of the German Cardiac Society 20091001
-
Angiotensin II receptor blocker candesartan cilexetil, but not hydralazine hydrochloride, protects against mouse cardiac enlargement resulting from undernutrition in utero.
Reproductive sciences (Thousand Oaks, Calif.) 20091001
-
Drug-induced lupus: an update on its dermatologic aspects.
Lupus 20091001
-
The effect of recombinant aminopeptidase A (APA) on hypertension in pregnant spontaneously hypertensive rats (SHRs).
Early human development 20090901
-
Effects of fixed-dose isosorbide dinitrate/hydralazine on diastolic function and exercise capacity in hypertension-induced diastolic heart failure.
Hypertension (Dallas, Tex. : 1979) 20090901
-
Heart failure in women: a need for prospective data.
Journal of the American College of Cardiology 20090804
-
Evidence for a noradrenergic mechanism causing hypertension and abnormal glucose metabolism in rats with relative deficiency of gamma-melanocyte-stimulating hormone.
Experimental physiology 20090801
-
Isosorbide dinitrate and hydralazine as therapy for African Americans with heart failure; a failed paradigm?
Clinical and translational science 20090801
-
Covalent binding of penicillamine to macrophages: implications for penicillamine-induced autoimmunity.
Chemical research in toxicology 20090701
-
Renal medullary effects of transient prehypertensive treatment in young spontaneously hypertensive rats.
Acta physiologica (Oxford, England) 20090601
-
ANG II infusion promotes abdominal aortic aneurysms independent of increased blood pressure in hypercholesterolemic mice.
American journal of physiology. Heart and circulatory physiology 20090501
-
Molecular modeling and molecular dynamics studies of hydralazine with human DNA methyltransferase 1.
ChemMedChem 20090501
-
Favorable cardiac and aortic remodeling in olmesartan-treated spontaneously hypertensive rats.
Heart and vessels 20090501
-
[Fever induced by various drugs].
Rinsho byori. The Japanese journal of clinical pathology 20090501
-
Usefulness of Isosorbide Dinitrate and Hydralazine as add-on therapy in patients discharged for advanced decompensated heart failure.
The American journal of cardiology 20090415
-
Uremic cardiac hypertrophy is reversed by rapamycin but not by lowering of blood pressure.
Kidney international 20090401
-
Lowering blood pressure blocks mesangiolysis and mesangial nodules, but not tubulointerstitial injury, in diabetic eNOS knockout mice.
The American journal of pathology 20090401
-
Protective effects of angiotensin AT1 receptor blockade in malignant hypertension in the rat.
European journal of pharmacology 20090401
-
Endothelial nitric oxide synthase (NOS3) polymorphisms in African Americans with heart failure: results from the A-HeFT trial.
Journal of cardiac failure 20090401
-
Hydralazine inhibits human cervical cancer cell growth in vitro in association with APC demethylation and re-expression.
Cancer chemotherapy and pharmacology 20090301
-
Formulation development of oral controlled release tablets of hydralazine: optimization of drug release and bioadhesive characteristics.
Acta pharmaceutica (Zagreb, Croatia) 20090301
-
Have we witnessed the rise and fall of race-specific drugs?
Clinical therapeutics 20090301
-
Effectiveness of hydralazine/isosorbide dinitrate in racial/ethnic subgroups with heart failure.
Clinical therapeutics 20090301
-
Pharmacotherapeutic options for the treatment of preeclampsia.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20090215
-
Pharmacologically induced angiogenesis in transgenic zebrafish.
Biochemical and biophysical research communications 20090123
-
Drug-induced lupus erythematosus.
Archives of dermatological research 20090101
-
'Pulse' treatment with high-dose angiotensin blocker reverses renal arteriolar hypertrophy and regresses hypertension.
Hypertension (Dallas, Tex. : 1979) 20090101
-
Urinary oxidative stress markers closely reflect the efficacy of candesartan treatment for diabetic nephropathy.
Nephron. Experimental nephrology 20090101
-
From the editors.
Cambridge quarterly of healthcare ethics : CQ : the international journal of healthcare ethics committees 20090101
-
Race-based medicine and justice as recognition: exploring the phenomenon of BiDil.
Cambridge quarterly of healthcare ethics : CQ : the international journal of healthcare ethics committees 20090101
-
Hydralazine-induced cholestatic hepatitis.
American journal of therapeutics 20090101
-
Bioactivation of organic nitrates and the mechanism of nitrate tolerance.
Cardiology journal 20090101
-
Hydralazine-induced ANCA-positive pauci-immune glomerulonephritis: a case report and literature review.
Renal failure 20090101
-
Improvement of endothelial function of the corpus cavernosum in apolipoprotein E knockout mice treated with irbesartan.
The Journal of pharmacology and experimental therapeutics 20081201
-
Increased tissue perfusion promotes capillary dysplasia in the ALK1-deficient mouse brain following VEGF stimulation.
American journal of physiology. Heart and circulatory physiology 20081201
-
Telmisartan prevents aneurysm progression in the rat by inhibiting proteolysis, apoptosis and inflammation.
Journal of hypertension 20081201
-
Azelnidipine decreases sympathetic nerve activity via antioxidant effect in the rostral ventrolateral medulla of stroke-prone spontaneously hypertensive rats.
Journal of cardiovascular pharmacology 20081201
-
Isosorbide dinitrate/hydralazine: its role in the treatment of heart failure.
Drugs of today (Barcelona, Spain : 1998) 20081201
-
Blood pressure versus direct mineralocorticoid effects on kidney inflammation and fibrosis in DOCA-salt hypertension.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20081101
-
Excess salt causes cerebral neuronal apoptosis and inflammation in stroke-prone hypertensive rats through angiotensin II-induced NADPH oxidase activation.
Stroke 20081101
-
Exploring the potential synergistic action of spironolactone on nitric oxide-enhancing therapy: insights from the African-American Heart Failure Trial.
Journal of cardiac failure 20081101
-
Salt sensitivity of blood pressure in NKCC1-deficient mice.
American journal of physiology. Renal physiology 20081001
-
[Recent findings on nitrates: their action, bioactivation and development of tolerance].
Deutsche medizinische Wochenschrift (1946) 20081001
-
Chronic intake of a phytochemical-enriched diet reduces cardiac fibrosis and diastolic dysfunction caused by prolonged salt-sensitive hypertension.
The journals of gerontology. Series A, Biological sciences and medical sciences 20081001
-
Candesartan-induced gene expression in five organs of stroke-prone spontaneously hypertensive rats.
Hypertension research : official journal of the Japanese Society of Hypertension 20081001
-
Exploiting race in drug development: BiDil's interim model of pharmacogenomics.
Social studies of science 20081001
-
Simultaneous posterior ischemic optic neuropathy, cerebral border zone infarction, and spinal cord infarction after correction of malignant hypertension.
Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society 20080901
-
Role of cardiac hypertrophy in reducing the sensitivity of cardiopulmonary reflex control of renal sympathetic nerve activity in spontaneously hypertensive rats.
Clinical and experimental pharmacology & physiology 20080901
-
Functionalized mesoporous silica nanoparticle-based drug delivery system to rescue acrolein-mediated cell death.
Nanomedicine (London, England) 20080801
-
Pharmacogenetics, race and global injustice.
Developing world bioethics 20080801
-
Hypertension induces somatic cellular senescence in rats and humans by induction of cell cycle inhibitor p16INK4a.
Hypertension (Dallas, Tex. : 1979) 20080701
-
Pharmacotherapy for heart failure with left ventricular dysfunction: beyond angiotensin-converting enzyme inhibitors and beta-blockers.
Pharmacotherapy 20080701
-
Hyperbaric oxygenation reduces overexpression of c-Fos and oxidative stress in the brain stem of experimental endotoxemic rats.
Intensive care medicine 20080601
-
Bidil: recontextualizing the race debate.
The pharmacogenomics journal 20080601
-
Hypertension impairs postnatal vasculogenesis: role of antihypertensive agents.
Hypertension (Dallas, Tex. : 1979) 20080601
-
Perioperative hypertension management.
Vascular health and risk management 20080601
-
Epigenetic and HIF-1 regulation of stanniocalcin-2 expression in human cancer cells.
Experimental cell research 20080501
-
Human atrial natriuretic peptide suppresses torsades de pointes in rabbits.
Circulation journal : official journal of the Japanese Circulation Society 20080501
-
DNA methylation in T cells from idiopathic lupus and drug-induced lupus patients.
Autoimmunity reviews 20080501
-
Deoxycorticosterone acetate-salt mice exhibit blood pressure-independent sexual dimorphism.
Hypertension (Dallas, Tex. : 1979) 20080401
-
Effect of endothelin receptor antagonists on ventricular susceptibility in postinfarcted rats.
American journal of physiology. Heart and circulatory physiology 20080401
-
Accelerated cytotoxic mechanism screening of hydralazine using an in vitro hepatocyte inflammatory cell peroxidase model.
Chemical research in toxicology 20080401
-
Carbonyl-scavenging drugs & protection against carbonyl stress-associated cell injury.
Mini reviews in medicinal chemistry 20080401
-
BiDil flops.
Nature biotechnology 20080301
-
Hydralazine inhibits compression and acrolein-mediated injuries in ex vivo spinal cord.
Journal of neurochemistry 20080201
-
Overexpression of angiotensinogen increases tubular apoptosis in diabetes.
Journal of the American Society of Nephrology : JASN 20080201
-
Effects of combined AT1 receptor antagonist/NEP inhibitor on vascular remodeling and cardiac fibrosis in SHRSP.
Journal of hypertension 20080201
-
[Special place of PETN among nitrates. No tolerance development, fewer headaches].
MMW Fortschritte der Medizin 20080117
-
Sustained hypertension increases the density of AMPA receptor subunit, GluR1, in baroreceptive regions of the nucleus tractus solitarii of the rat.
Brain research 20080102
-
Applicability of recent methods used to estimate spontaneous baroreflex sensitivity to resting mice.
American journal of physiology. Regulatory, integrative and comparative physiology 20080101
-
Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
Clinical and experimental pharmacology & physiology 20080101
-
Magnesium sulphate therapy in women with pre-eclampsia and eclampsia in Kuwait.
Medical principles and practice : international journal of the Kuwait University, Health Science Centre 20080101
-
Introduction: Facts and fictions: BiDil and the resurgence of racial medicine.
The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics 20080101
-
Flaws in the U.S. Food and Drug Administration's rationale for supporting the development and approval of BiDil as a treatment for heart failure only in black patients.
The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics 20080101
-
Fixed-dose isosorbide dinitrate-hydralazine: race-based cardiovascular medicine benefit or mirage?
The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics 20080101
-
Genotyping the future: scientists' expectations about race/ ethnicity after BiDil.
The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics 20080101
-
'Special treatment': BiDil, Tuskegee, and the logic of race.
The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics 20080101
-
Popular representations of race: the news coverage of BiDil.
The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics 20080101
-
Vascular endothelial growth factor receptor 1 (Flt1) and apoptosis in the preeclamptic placenta and effects of in vivo anti-hypertensive exposure.
Hypertension in pregnancy 20080101
-
[Osteogenesis of human vascular endothelial cells in culture].
Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion 20080101
-
Synergetic antioxidant and vasodilatory action of carbon monoxide in angiotensin II - induced cardiac hypertrophy.
Hypertension (Dallas, Tex. : 1979) 20071201
-
Novel mechanism and role of angiotensin II induced vascular endothelial injury in hypertensive diastolic heart failure.
Arteriosclerosis, thrombosis, and vascular biology 20071201
-
The effects of hydralazine on lipolysis in subcutaneous adipose tissue in humans.
Metabolism: clinical and experimental 20071201
-
Persistent hypertension and progressive renal injury induced by salt overload after short term nitric oxide inhibition.
Clinics (Sao Paulo, Brazil) 20071201
-
Blood pressure control in Hispanics in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.
Hypertension (Dallas, Tex. : 1979) 20071101
-
Intermolecular protein cross-linking during acrolein toxicity: efficacy of carbonyl scavengers as inhibitors of heat shock protein-90 cross-linking in A549 cells.
Chemical research in toxicology 20071101
-
[Drug-induced lupus erythematosus].
Nihon rinsho. Japanese journal of clinical medicine 20071028
-
Genetic disruption of guanylyl cyclase/natriuretic peptide receptor-A upregulates ACE and AT1 receptor gene expression and signaling: role in cardiac hypertrophy.
Physiological genomics 20071022
-
Chronic sodium hydrosulfide treatment decreases medial thickening of intramyocardial coronary arterioles, interstitial fibrosis, and ROS production in spontaneously hypertensive rats.
American journal of physiology. Heart and circulatory physiology 20071001
-
Amlodipine inhibits granulation tissue cell apoptosis through reducing calcineurin activity to attenuate postinfarction cardiac remodeling.
American journal of physiology. Heart and circulatory physiology 20071001
-
Reducing blood pressure in SHR with enalapril provokes redistribution of NHE3, NaPi2, and NCC and decreases NaPi2 and ACE abundance.
American journal of physiology. Renal physiology 20071001
-
Olmesartan ameliorates renovascular injury and oxidative stress in Zucker obese rats enhanced by dietary protein.
American journal of hypertension 20071001
-
A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors.
Annals of oncology : official journal of the European Society for Medical Oncology 20070901
-
Simvastatin reverses target organ damage and oxidative stress in Angiotensin II hypertension: comparison with apocynin, tempol, and hydralazine.
Journal of cardiovascular pharmacology 20070901
-
Evidence for the continued safety and tolerability of fixed-dose isosorbide dinitrate/hydralazine in patients with chronic heart failure (the extension to African-American Heart Failure Trial).
The American journal of cardiology 20070815
-
BiDil for heart failure in black patients.
Annals of internal medicine 20070807
-
BiDil for heart failure in black patients.
Annals of internal medicine 20070807
-
Cardioprotective effect of angiotensin II type 1 receptor antagonist associated with bradykinin-endothelial nitric oxide synthase and oxidative stress in Dahl salt-sensitive hypertensive rats.
Journal of hypertension 20070801
-
A randomised comparison of hydralazine and mini-bolus diazoxide for hypertensive emergencies in pregnancy: the PIVOT trial.
The Australian & New Zealand journal of obstetrics & gynaecology 20070801
-
Angiotensin inhibition decreases progression of advanced atherosclerosis and stabilizes established atherosclerotic plaques.
Journal of the American Society of Nephrology : JASN 20070801
-
Angiotensin II type 1 receptor blocker reduces monocyte adhesion to endothelial cells in spontaneously hypertensive rats.
Endocrine journal 20070801
-
Race in a bottle. Drugmakers are eager to develop medicines targeted at ethnic groups, but so far they have made poor choices based on unsound science.
Scientific American 20070801
-
Paradoxical role of angiotensin II type 2 receptors in resistance arteries of old rats.
Hypertension (Dallas, Tex. : 1979) 20070701
-
Prevention of hypertension abrogates early inflammatory events in the retina of diabetic hypertensive rats.
Experimental eye research 20070701
-
The paradox of race in the Bidil debate.
Journal of the National Medical Association 20070701
-
There is no scientific rationale for race-based research.
Journal of the National Medical Association 20070601
-
What's right (and wrong) with racially stratified research and therapies.
Journal of the National Medical Association 20070601
-
BiDil: primary care physicians first and cardiologist when?
Journal of the National Medical Association 20070601
-
Isosorbide dinitrate and hydralazine in a fixed-dose combination produces further regression of left ventricular remodeling in a well-treated black population with heart failure: results from A-HeFT.
Journal of cardiac failure 20070601
-
Early and sustained benefit on event-free survival and heart failure hospitalization from fixed-dose combination of isosorbide dinitrate/hydralazine: consistency across subgroups in the African-American Heart Failure Trial.
Circulation 20070403
-
Blood pressure lowering after experimental cerebral ischemia provides neurovascular protection.
Journal of hypertension 20070401
-
African American heart failure trial: role of endothelial dysfunction and heart failure in African Americans.
The American journal of cardiology 20070326
-
Isosorbide dinitrate-hydralazine improves outcomes in African Americans with heart failure.
Cleveland Clinic journal of medicine 20070301
-
Presentation and outcome of eclampsia at a Nigerian university hospital.
Nigerian journal of clinical practice 20070301
-
Time course of vascular arginase expression and activity in spontaneously hypertensive rats.
Life sciences 20070227
-
Medicalisation of race.
Lancet (London, England) 20070224
-
ANG II type 1A receptor signaling causes unfavorable scar dynamics in the postinfarct heart.
American journal of physiology. Heart and circulatory physiology 20070201
-
Optimal frequency ranges for extracting information on cardiovascular autonomic control from the blood pressure and pulse interval spectrograms in mice.
American journal of physiology. Regulatory, integrative and comparative physiology 20070201
-
Podocyte as the target for aldosterone: roles of oxidative stress and Sgk1.
Hypertension (Dallas, Tex. : 1979) 20070201
-
Editorial commentary on fixed combination isosorbide dinitrate/hydralazine for nitric-oxide-enhancing therapy in heart failure.
Expert opinion on pharmacotherapy 20070201
-
Angiostatin does not contribute to skeletal muscle microvascular rarefaction with low nitric oxide bioavailability.
Microcirculation (New York, N.Y. : 1994) 20070201
-
BiDil for heart failure in black patients: implications of the U.S. Food and Drug Administration approval.
Annals of internal medicine 20070102
-
BiDil for heart failure in black patients: The U.S. Food and Drug Administration perspective.
Annals of internal medicine 20070102
-
Influence of blood pressure on the effectiveness of a fixed-dose combination of isosorbide dinitrate and hydralazine in the African-American Heart Failure Trial.
Journal of the American College of Cardiology 20070102
-
Regulation of renin in mice with Cre recombinase-mediated deletion of G protein Gsalpha in juxtaglomerular cells.
American journal of physiology. Renal physiology 20070101
-
Structure-toxicity analysis of type-2 alkenes: in vitro neurotoxicity.
Toxicological sciences : an official journal of the Society of Toxicology 20070101
-
Transient AT1 receptor-inhibition in prehypertensive spontaneously hypertensive rats results in maintained cardiac protection until advanced age.
Journal of hypertension 20070101
-
BiDil (isosorbide dinitrate and hydralazine): a new fixed-dose combination of two older medications for the treatment of heart failure in black patients.
Cardiology in review 20070101
-
The effects of DNA methylation and histone deacetylase inhibitors on human papillomavirus early gene expression in cervical cancer, an in vitro and clinical study.
Virology journal 20070101
-
Hypotensive effect of hydroxylamine, an endogenous nitric oxide donor and SSAO inhibitor.
Journal of neural transmission (Vienna, Austria : 1996) 20070101
-
Management of severe hypertension in the postpartum period with intravenous hydralazine or labetalol: a randomized clinical trial.
Hypertension in pregnancy 20070101
-
Lack of bioequivalence between different formulations of isosorbide dinitrate and hydralazine and the fixed-dose combination of isosorbide dinitrate/hydralazine: the V-HeFT paradox.
Clinical pharmacokinetics 20070101
-
Evidence-based treatment of chronic heart failure.
Comprehensive therapy 20070101
-
Effects of ACE inhibitors or beta-blockers in patients treated with the fixed-dose combination of isosorbide dinitrate/hydralazine in the African-American Heart Failure Trial.
American journal of cardiovascular drugs : drugs, devices, and other interventions 20070101
-
Outcomes by gender in the African-American Heart Failure Trial.
Journal of the American College of Cardiology 20061205
-
Effect of pravastatin on left ventricular mass in the two-kidney, one-clip hypertensive rats.
American journal of physiology. Heart and circulatory physiology 20061201
-
Expression and localization of PDGF-B, PDGF-D, and PDGF receptor in the kidney of angiotensin II-infused rat.
Laboratory investigation; a journal of technical methods and pathology 20061201
-
Effects of angiotensin II on NO bioavailability evaluated using a catheter-type NO sensor.
Hypertension (Dallas, Tex. : 1979) 20061201
-
Fixed combination isosorbide dinitrate-hydralazine for nitric-oxide-enhancing therapy in heart failure.
Expert opinion on pharmacotherapy 20061201
-
Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
American journal of hypertension 20061201
-
Isosorbide dinitrate-hydralazine combination therapy in African Americans with heart failure.
Vascular health and risk management 20061201
-
Systemic cholecystokinin differentially affects baro-activated GABAergic neurons in rat caudal ventrolateral medulla.
Journal of neurophysiology 20061101
-
BiDil: assessing a race-based pharmaceutical.
Annals of family medicine 20061101
-
Enhancement of cardiac oxidative stress by tachycardia and its critical role in cardiac hypertrophy and fibrosis.
Journal of hypertension 20061001
-
Aldosterone synthase promoter polymorphism predicts outcome in African Americans with heart failure: results from the A-HeFT Trial.
Journal of the American College of Cardiology 20060919
-
Response to the February 2006 Journal of Cardiac Failure Editor's comment.
Journal of cardiac failure 20060801
-
Prescribing BiDil: is it black and white?
Journal of the American College of Cardiology 20060704
-
Diagnosis and management of chronic heart failure.
Journal of the American College of Cardiology 20060704
-
Hydralazine rescues PC12 cells from acrolein-mediated death.
Journal of neuroscience research 20060701
-
Differences between Candesartan and Hydralazine in the protection of penile structures in spontaneously hypertensive rats.
The journal of sexual medicine 20060701
-
Increased intracavernosal pressure response in hypertensive rats after chronic hemin treatment.
The journal of sexual medicine 20060701
-
Pharmacotherapy implications of revised chronic heart failure guidelines.
The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 20060701
-
Determination of hydralazine with flow injection chemiluminescence sensor using molecularly imprinted polymer as recognition element.
Journal of pharmaceutical and biomedical analysis 20060607
-
Podocyte injury underlies the glomerulopathy of Dahl salt-hypertensive rats and is reversed by aldosterone blocker.
Hypertension (Dallas, Tex. : 1979) 20060601
-
ACE inhibition restores the vasodilator potency of the endothelium-derived relaxing factor, L-S-nitrosocysteine, in conscious Spontaneously Hypertensive rats.
Vascular pharmacology 20060601
-
Using race in clinical research to develop tailored medications. Is the FDA encouraging discrimination or eliminating traditional disparities in health care for African Americans?
The Journal of legal medicine 20060601
-
Pharmacological treatment of chronic heart failure.
Heart failure reviews 20060601
-
Endothelial progenitor cell differentiation and senescence in an angiotensin II-infusion rat model.
Hypertension research : official journal of the Japanese Society of Hypertension 20060601
-
Antihypertensive drugs clonidine, diazoxide, hydralazine and furosemide regulate the production of cytokines by placentas and peripheral blood mononuclear cells in normal pregnancy.
Journal of hypertension 20060501
-
Effects of angiotensin II type 1 receptor blockade on the systemic blood nitric oxide dynamics in Nomega-nitro-L-arginine methyl ester-treated rats.
Hypertension research : official journal of the Japanese Society of Hypertension 20060501
-
A review of isosorbide dinitrate and hydralazine in the management of heart failure in black patients, with a focus on a new fixed-dose combination.
Clinical therapeutics 20060501
-
Angiotensin II type 1 receptor blocker prevents atrial structural remodeling in rats with hypertension induced by chronic nitric oxide inhibition.
Hypertension research : official journal of the Japanese Society of Hypertension 20060401
-
Desensitization of platelet-derived growth factor receptor-beta by oxidized lipids in vascular cells and atherosclerotic lesions: prevention by aldehyde scavengers.
Circulation research 20060331
-
Differential expression of components of the cardiomyocyte adrenomedullin/intermedin receptor system following blood pressure reduction in nitric oxide-deficient hypertension.
The Journal of pharmacology and experimental therapeutics 20060301
-
Effect of the angiotensin II receptor blocker olmesartan on the development of murine acute myocarditis caused by coxsackievirus B3.
Clinical science (London, England : 1979) 20060301
-
Hydralazine inhibits rapid acrolein-induced protein oligomerization: role of aldehyde scavenging and adduct trapping in cross-link blocking and cytoprotection.
Molecular pharmacology 20060301
-
Should drug therapy be personalized based on race?
The Annals of pharmacotherapy 20060301
-
The isosorbide-hydralazine story: is there a case for race-based cardiovascular medicine?
Journal of clinical hypertension (Greenwich, Conn.) 20060301
-
Expression of endothelial nitric oxide synthase is suppressed in the renal vasculature of angiotensinogen-gene knockout mice.
Cell and tissue research 20060201
-
Antiatherogenic effects of angiotensin receptor antagonism in mild renal dysfunction.
Journal of the American Society of Nephrology : JASN 20060201
-
A look back at the most influential drug approvals of 2005.
The Nurse practitioner 20060201
-
Synthetic smooth muscle cell phenotype is associated with increased nicotinamide adenine dinucleotide phosphate oxidase activity: effect on collagen secretion.
Journal of vascular surgery 20060201
-
Kinetics and mechanisms of cholesterol esterase inhibition by cardiovascular drugs in vitro.
Indian journal of biochemistry & biophysics 20060201
-
Role of angiotensin type-1 and angiotensin type-2 receptors in the expression of vascular integrins in angiotensin II-infused rats.
Hypertension (Dallas, Tex. : 1979) 20060101
-
Impact of antihypertensive treatments on erectile responses in aging spontaneously hypertensive rats.
Journal of hypertension 20060101
-
Minimal change disease in association with fire coral (Millepora species) exposure.
American journal of kidney diseases : the official journal of the National Kidney Foundation 20060101
-
BiDil (isosorbide dinitrate and hydralazine hydrochloride).
Congestive heart failure (Greenwich, Conn.) 20060101
-
Severe hypertension in pregnancy: hydralazine or labetalol. A randomized clinical trial.
European journal of obstetrics, gynecology, and reproductive biology 20060101
-
Being specific about race-specific medicine.
Health affairs (Project Hope) 20060101
-
BiDil: from another vantage point.
Health affairs (Project Hope) 20060101
-
Race, pharmacogenomics, and marketing: putting BiDil in context.
The American journal of bioethics : AJOB 20060101
-
The use of race and ethnicity in medicine: lessons from the African-American Heart Failure Trial.
The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics 20060101
-
Race, money and medicines.
The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics 20060101
-
Transient improvement of hypertension-induced chronic renal failure with mycophenolate mofetil treatment.
Renal failure 20060101
-
A proof-of-principle study of epigenetic therapy added to neoadjuvant doxorubicin cyclophosphamide for locally advanced breast cancer.
PloS one 20060101
-
[Treatment effectiveness of hypertension during pregnancy].
Revista da Associacao Medica Brasileira (1992) 20060101
-
Hydralazine is a powerful inhibitor of peroxynitrite formation as a possible explanation for its beneficial effects on prognosis in patients with congestive heart failure.
Biochemical and biophysical research communications 20051230
-
Cost-effectiveness of fixed-dose combination of isosorbide dinitrate and hydralazine therapy for blacks with heart failure.
Circulation 20051213
-
Blockade of angiotensin II provides additional benefits in hypertension- and ageing-related cardiac and vascular dysfunctions beyond its blood pressure-lowering effects.
Journal of hypertension 20051201
-
Single-unit responses of serotonergic medullary raphe neurons to cardiovascular challenges in freely moving cats.
The European journal of neuroscience 20051201
-
'Racially-tailored' medicine unraveled.
The American University law review 20051201
-
On the selling of pharmaceuticals.
Journal of the American College of Cardiology 20051115
-
BiDil's impact.
Nature biotechnology 20051101
-
Isosorbide dinitrate and hydralazine hydrochloride: a review of efficacy and safety.
Expert review of cardiovascular therapy 20051101
-
Gray area for new heart failure drug. Although the FDA approved BiDil for blacks with heart failure, it may work in anyone.
Harvard heart letter : from Harvard Medical School 20051101
-
Hydralazine decreases sodium nitroprusside-induced rat aortic ring relaxation and increased cGMP production by rat aortic myocytes.
Life sciences 20051028
-
Approval of drug marketed to African Americans raises political, economic issues. Study criticizes manufacturer for re-branding generic drug with race-specific indication.
Medicine & health (1997) 20051024
-
The oxidative stress concept of nitrate tolerance and the antioxidant properties of hydralazine.
The American journal of cardiology 20051010
-
Effects of nitrates and hydralazine in heart failure: clinical evidence before the african american heart failure trial.
The American journal of cardiology 20051010
-
Vasodilator treatment with hydralazine increases blood flow in mdx mice resistance arteries without vascular wall remodelling or endothelium function improvement.
Journal of hypertension 20051001
-
Update on outpatient treatment of systolic heart failure.
American family physician 20051001
-
Comparison of biological effects of non-nucleoside DNA methylation inhibitors versus 5-aza-2'-deoxycytidine.
Molecular cancer therapeutics 20051001
-
One-pot construction of pyrazoles and isoxazoles with palladium-catalyzed four-component coupling.
Organic letters 20050929
-
BiDil for heart failure.
The Medical letter on drugs and therapeutics 20050926
-
Angiotensin II AT1 receptors regulate ACE2 and angiotensin-(1-7) expression in the aorta of spontaneously hypertensive rats.
American journal of physiology. Heart and circulatory physiology 20050901
-
Combined angiotensin II type 1 and type 2 receptor blockade on vascular remodeling and matrix metalloproteinases in resistance arteries.
Hypertension (Dallas, Tex. : 1979) 20050901
-
2-bromoethylamine, a suicide inhibitor of semicarbazide-sensitive amine oxidase, increases hydralazine hypotension in rats.
Journal of cardiovascular pharmacology 20050901
-
New heart-failure therapy takes race into account.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20050901
-
Novel heart failure drug may offer options for you.
Heart advisor 20050901
-
Drugs tailored to race move a step closer to reality.
Drug discovery today 20050815
-
Role of natriuretic peptide receptor guanylyl cyclase-A in myocardial infarction evaluated using genetically engineered mice.
Hypertension (Dallas, Tex. : 1979) 20050801
-
The impact of race on response to RAAS inhibition.
Current heart failure reports 20050801
-
Combination pharmacologic therapies for heart failure: what next after angiotensin-converting enzyme inhibitors and beta-blockers?
Current heart failure reports 20050801
-
Endothelin-1 contributes to the sexual differences in renal damage in DOCA-salt rats.
Peptides 20050801
-
Illuminating BiDil.
Nature biotechnology 20050801
-
BiDil raises questions about race as a marker.
Nature reviews. Drug discovery 20050801
-
Maker of heart drug intended for blacks bases price on patients' wealth.
The New York times on the Web 20050708
-
Inhibition of NF-kappaB induces regression of cardiac hypertrophy, independent of blood pressure control, in spontaneously hypertensive rats.
American journal of physiology. Heart and circulatory physiology 20050701
-
Stimulation of soluble guanylate cyclase slows progression in anti-thy1-induced chronic glomerulosclerosis.
Kidney international 20050701
-
Misreading race and genomics after BiDil.
Nature genetics 20050701
-
Race, drugs, and heart failure.
Geriatrics 20050701
-
[Immunologic tests: Anti-histone antibodies].
Nihon rinsho. Japanese journal of clinical medicine 20050701
-
Food & Drug Administration panel approves heart failure medication aimed at African-Americans.
Pharmacogenomics 20050701
-
Pharmacogenetics and ethnically targeted therapies: racial drugs need to be put in context.
BMJ (Clinical research ed.) 20050625
-
F.D.A. approves a heart drug for African-Americans.
The New York times on the Web 20050624
-
Drug targeting: is race enough?
Nature 20050623
-
F.D.A. panel approves heart remedy for blacks.
The New York times on the Web 20050617
-
U.S. to review drug intended for one race.
The New York times on the Web 20050613
-
Color blind, or just plain blind?
Alternative medicine review : a journal of clinical therapeutic 20050601
-
Not black and white: BiDil may work best for African Americans--but do we know why?
New scientist (1971) 20050601
-
Colour-coded cures.
New scientist (1971) 20050601
-
Demethylation of the same promoter sequence increases CD70 expression in lupus T cells and T cells treated with lupus-inducing drugs.
Journal of immunology (Baltimore, Md. : 1950) 20050515
-
Site-dependent inhibition of neuronal c-jun in the brainstem elicited by imidazoline I1 receptor activation: role in rilmenidine-evoked hypotension.
European journal of pharmacology 20050509
-
Pharmacogenetics and ethnically targeted therapies.
BMJ (Clinical research ed.) 20050507
-
Long-term inhibition of angiotensin prevents reduction of periarterial innervation of calcitonin gene-related peptide (CGRP)-containing nerves in spontaneously hypertensive rats.
Hypertension research : official journal of the Japanese Society of Hypertension 20050501
-
Drug success signals a new trend. A 'race-based' medication is a step toward individualized care.
Heart advisor 20050401
-
Intravascular contrast agent-enhanced MRI measuring contrast clearance and tumor blood volume and the effects of vascular modifiers in an experimental tumor.
International journal of radiation oncology, biology, physics 20050315
-
Isosorbide dinitrate and hydralazine in blacks with heart failure.
The New England journal of medicine 20050310
-
Isosorbide dinitrate and hydralazine in blacks with heart failure.
The New England journal of medicine 20050310
-
Isosorbide dinitrate and hydralazine in blacks with heart failure.
The New England journal of medicine 20050310
-
Isosorbide dinitrate and hydralazine in blacks with heart failure.
The New England journal of medicine 20050310
-
Temporary angiotensin II blockade at the prediabetic stage attenuates the development of renal injury in type 2 diabetic rats.
Journal of the American Society of Nephrology : JASN 20050301
-
Race and a heart drug.
Minnesota medicine 20050301
-
Medicine. Race and reification in science.
Science (New York, N.Y.) 20050218
-
Control of oxidative stress in microcirculation of spontaneously hypertensive rats.
American journal of physiology. Heart and circulatory physiology 20050201
-
Studying treatment of heart failure in blacks.
The American journal of nursing 20050201
-
The year in heart failure: 2004.
Journal of cardiac failure 20050201
-
Synthesis and luminescence properties of lanthanide complexes incorporating a hydralazine-derived chromophore.
Dalton transactions (Cambridge, England : 2003) 20050107
-
Influence of neonatal sympathectomy on proximal renal resistance artery function in spontaneously hypertensive rats.
Pflugers Archiv : European journal of physiology 20050101
-
'Ethnic drugs'.
The Hastings Center report 20050101
-
A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes.
BMC cancer 20050101
-
BiDil: race medicine or race marketing?
Health affairs (Project Hope) 20050101
-
The case of BiDil: a policy commentary on race and genetics.
Health affairs (Project Hope) 20050101
-
Ethnic pharmacology: science, research, race, and market share.
Clinical nurse specialist CNS 20050101
-
A-HeFT: old dog, new endothelial tricks.
Texas Heart Institute journal 20050101
-
FDA approves heart drug for black patients.
FDA consumer 20050101
-
BiDil: false promises: faulty statistics and reasoning have lead to the first 'racial medicine'.
Genewatch : a bulletin of the Committee for Responsible Genetics 20050101
-
From disparity to difference: how race-specific medicines may undermine policies to address inequalities in health care.
Southern California interdisciplinary law journal 20050101
-
Genome-wide demethylation destabilizes CTG.CAG trinucleotide repeats in mammalian cells.
Human molecular genetics 20041201
-
Magnesium inhibits norepinephrine release by blocking N-type calcium channels at peripheral sympathetic nerve endings.
Hypertension (Dallas, Tex. : 1979) 20041201
-
The expression of heme oxygenase-1 and inducible nitric oxide synthase in aorta during the development of hypertension in spontaneously hypertensive rats.
American journal of hypertension 20041201
-
Heart failure after Caesarean section for twin delivery.
European journal of anaesthesiology 20041201
-
A cure for a race? Heart drug findings set off ethics debate.
The Washington post 20041116
-
Combination of isosorbide dinitrate and hydralazine in blacks with heart failure.
The New England journal of medicine 20041111
-
Race-based therapeutics.
The New England journal of medicine 20041111
-
Nitroso-redox balance in the cardiovascular system.
The New England journal of medicine 20041111
-
Role of neurokinin 3 receptors in supraoptic vasopressin and oxytocin neurons.
The Journal of neuroscience : the official journal of the Society for Neuroscience 20041110
-
Inhibition of diet-induced atherosclerosis and endothelial dysfunction in apolipoprotein E/angiotensin II type 1A receptor double-knockout mice.
Circulation 20041109
-
In vivo determination of tumor oxygenation during growth and in response to carbogen breathing using 15C5-loaded alginate capsules as fluorine-19 magnetic resonance imaging oxygen sensors.
International journal of radiation oncology, biology, physics 20041101
-
The treatment of severe hypertension in pregnancy: a review of current practice and knowledge in West-Midlands maternity units.
Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 20041101
-
Reactivity of hydrazinophthalazine drugs with the lipid peroxidation products acrolein and crotonaldehyde.
Organic & biomolecular chemistry 20040921
-
Strong protein adduct trapping accompanies abolition of acrolein-mediated hepatotoxicity by hydralazine in mice.
The Journal of pharmacology and experimental therapeutics 20040901
-
Postcards: race and medicine in the 21st century.
The British journal of general practice : the journal of the Royal College of General Practitioners 20040901
-
Parabrachial inputs to Fos-immunoreactive neurons in the lateral central nucleus of amygdala activated by hypotension: a light and electron microscopic study in the rat.
Brain research bulletin 20040830
-
Novel mechanism of action for hydralazine: induction of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by inhibition of prolyl hydroxylases.
Circulation research 20040723
-
Alterations in renal endothelial nitric oxide synthase expression by salt diet in angiotensin type-1a receptor gene knockout mice.
Journal of the American Society of Nephrology : JASN 20040701
-
Olmesartan improves endothelin-induced hypertension and oxidative stress in rats.
Hypertension research : official journal of the Japanese Society of Hypertension 20040701
-
Eplerenone prevents salt-induced vascular remodeling and cardiac fibrosis in stroke-prone spontaneously hypertensive rats.
Hypertension (Dallas, Tex. : 1979) 20040601
-
Increased infarct size in uremic rats: reduced ischemia tolerance?
Journal of the American Society of Nephrology : JASN 20040601
-
Hydralazine treatment alters body composition in the rabbit model of obesity.
Acta physiologica Scandinavica 20040601
-
Angiotensin II-induced effects on adipose and skeletal muscle tissue blood flow and lipolysis in normal-weight and obese subjects.
The Journal of clinical endocrinology and metabolism 20040601
-
Severe hypertension and massive proteinuria in a newborn with renal artery stenosis.
Pediatric nephrology (Berlin, Germany) 20040501
-
Effects of long-term ovariectomy and estrogen replacement on clonidine-evoked reductions in blood pressure and hemodynamic variability.
Journal of cardiovascular pharmacology 20040501
-
[Carbonyl stress inhibitor towards new therapeutic interventions in diabetic nephropathy].
Nihon rinsho. Japanese journal of clinical medicine 20040501
-
Elevated arterial pressure impairs autoregulation independently of AT(1) receptor activation.
Journal of hypertension 20040401
-
Effects of tempol on renal angiotensinogen production in Dahl salt-sensitive rats.
Biochemical and biophysical research communications 20040312
-
Hydralazine as antihypertensive therapy in obesity-related hypertension.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 20040301
-
Tight blood pressure control decreases apoptosis during renal damage.
Kidney international 20040301
-
Protein adduct-trapping by hydrazinophthalazine drugs: mechanisms of cytoprotection against acrolein-mediated toxicity.
Molecular pharmacology 20040301
-
Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice.
Journal of hypertension 20040301
-
Heat shock treatment protects against angiotensin II-induced hypertension and inflammation in aorta.
Cell stress & chaperones 20040301
-
Rho/Rho-kinase pathway in the brainstem contributes to hypertension caused by chronic nitric oxide synthase inhibition.
Hypertension (Dallas, Tex. : 1979) 20040201
-
Antioxidant activity and inhibitory effects of hydralazine on inducible NOS/COX-2 gene and protein expression in rat peritoneal macrophages.
International immunopharmacology 20040201
-
Blood pressure lability and glomerulosclerosis after normotensive 5/6 renal mass reduction in the rat.
Kidney international 20040101
-
How a drug becomes 'ethnic': law, commerce, and the production of racial categories in medicine.
Yale journal of health policy, law, and ethics 20040101
-
Periprocedural hypertension: current concepts in management for the vascular surgeon.
Vascular and endovascular surgery 20040101
-
Anti-hypertensive therapy and the feto-placental circulation: effects on umbilical artery resistance.
Journal of perinatal medicine 20040101
-
Endothelial dysfunction and nitric oxide enhancing therapy: a new approach to the treatment of heart failure.
Congestive heart failure (Greenwich, Conn.) 20040101
-
Color blind.
Genome biology 20040101
-
Race as a proxy for drug response: the dangers and challenges of ethnic drugs.
De Paul law review 20040101
-
Semicarbazide-sensitive amine oxidase substrates potentiate hydralazine hypotension: possible role of hydrogen peroxide.
The Journal of pharmacology and experimental therapeutics 20031101
-
Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis.
BMJ (Clinical research ed.) 20031025
-
Contribution of blood pressure variability to the effect of nitrendipine on end-organ damage in spontaneously hypertensive rats.
Journal of hypertension 20031001
-
Spironolactone prevents cardiac collagen proliferation after myocardial infarction in rats.
Clinical and experimental pharmacology & physiology 20031001
-
DNA methylation and autoimmune disease.
Clinical immunology (Orlando, Fla.) 20031001
-
New reactions of IBX: oxidation of nitrogen- and sulfur-containing substrates to afford useful synthetic intermediates.
Angewandte Chemie (International ed. in English) 20030905
-
Brain nitric oxide synthase activity in spontaneously hypertensive rats during the development of hypertension.
Journal of hypertension 20030901
-
Maternal benefit of high-dose intravenous corticosteroid therapy for HELLP syndrome.
American journal of obstetrics and gynecology 20030901
-
Endothelin antagonism on aldosterone-induced oxidative stress and vascular remodeling.
Hypertension (Dallas, Tex. : 1979) 20030701
-
Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations.
The American journal of cardiology 20030508
-
Regression of renal vascular and glomerular fibrosis: role of angiotensin II receptor antagonism and matrix metalloproteinases.
Journal of the American Society of Nephrology : JASN 20030501
-
Anti-hypertensive agents inhibit in vivo the formation of advanced glycation end products and improve renal damage in a type 2 diabetic nephropathy rat model.
Journal of the American Society of Nephrology : JASN 20030501
-
Reactivation of tumor suppressor genes by the cardiovascular drugs hydralazine and procainamide and their potential use in cancer therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 20030501
-
Interleukin-18 in the plasma of women with preeclampsia.
American journal of obstetrics and gynecology 20030501
-
Evaluation of hydralazine and procainamide effects on fibroblast membrane fluidity.
Biochimie 20030501
-
Preventing L-NAME inhibitory effects on rat sexual behavior with hydralazine, isradipine or captopril co-treatment.
Pharmacology, biochemistry, and behavior 20030501
-
An approach to identifying novel substrates of bacterial arylamine N-acetyltransferases.
Bioorganic & medicinal chemistry 20030403
-
Persistent lowering of arterial pressure after continuous and intermittent therapy.
Journal of hypertension 20030401
-
Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study.
Lancet (London, England) 20030329
-
Hydralazine may induce autoimmunity by inhibiting extracellular signal-regulated kinase pathway signaling.
Arthritis and rheumatism 20030301
-
The vasodilatory effects of hydralazine, nicardipine, nitroglycerin, and fenoldopam in the human umbilical artery.
Anesthesia and analgesia 20030201
-
Reflex bradycardia induced by hydralazine in sino-aortic deafferented conscious rats.
Autonomic & autacoid pharmacology 20030201
-
American College of Cardiology/American Heart Association Chronic Heart Failure Evaluation and Management guidelines: relevance to the geriatric practice.
Journal of the American Geriatrics Society 20030101
-
Resistance artery mechanics and composition in angiotensin II-infused rats: effects of aldosterone antagonism.
Journal of hypertension 20030101
-
Analysis of endothelium-dependent vasodilation by use of the radial artery pulse wave obtained by applanation tonometry.
Clinical physiology and functional imaging 20030101
-
[Opening of ATP-sensitive potassium channel attenuates cardiac remodeling induced by chronic inhibition of nitric oxide synthesis].
Journal of cardiology 20030101
-
Effects of hydrazine derivatives on vascular smooth muscle contractility, blood pressure and cGMP production in rats: comparison with hydralazine.
Vascular pharmacology 20030101
-
Getting the numbers right: statistical mischief and racial profiling in heart failure research.
Perspectives in biology and medicine 20030101
-
Differential effects of sodium nitroprusside and hydralazine in a rat model of topical FeCl3-induced carotid artery thrombosis.
Thrombosis research 20030101
-
Aldehyde-sequestering drugs: tools for studying protein damage by lipid peroxidation products.
Toxicology 20021227
-
Semicarbazide-sensitive amine oxidase (SSAO) gene expression in alloxan-induced diabetes in mice.
Molecular medicine (Cambridge, Mass.) 20021201
-
Impact of hydroxymethylglutaryl coenzyme a reductase inhibition on left ventricular remodeling after myocardial infarction: an experimental serial cardiac magnetic resonance imaging study.
Journal of the American College of Cardiology 20021106
-
Hydralazine reduces the quantal size of secretory events by displacement of catecholamines from adrenomedullary chromaffin secretory vesicles.
Circulation research 20021101
-
Clinical treatment regimens for chronic heart failure: a review.
Expert opinion on pharmacotherapy 20021101
-
Opening of the adenosine triphosphate-sensitive potassium channel attenuates cardiac remodeling induced by long-term inhibition of nitric oxide synthesis: role of 70-kDa S6 kinase and extracellular signal-regulated kinase.
Journal of the American College of Cardiology 20020904
-
Decompensated hemorrhage activates serotonergic neurons in the subependymal parapyramidal region of the rat medulla.
American journal of physiology. Regulatory, integrative and comparative physiology 20020901
-
Angiotensin converting enzyme inhibition decreases cell turnover in the neonatal rat heart.
Pediatric research 20020901
-
The African-American Heart Failure Trial: background, rationale and significance.
Journal of the National Medical Association 20020901
-
Contemporary treatment of heart failure: is there adequate evidence to support a unique strategy for African-Americans? Con position.
Current hypertension reports 20020801
-
Sympathetic-renal interaction in chronic arterial pressure control.
American journal of physiology. Regulatory, integrative and comparative physiology 20020801
-
Resistance to neointimal hyperplasia and fatty streak formation in mice with adrenomedullin overexpression.
Arteriosclerosis, thrombosis, and vascular biology 20020801
-
Chronic hydralazine improves flow (shear stress)-induced endothelium-dependent dilation in mouse mesenteric resistance arteries in vitro.
Microvascular research 20020701
-
African-American Heart Failure Trial (A-HeFT): rationale, design, and methodology.
Journal of cardiac failure 20020601
-
Predominant activation of endothelin-dependent cardiac hypertrophy by norepinephrine in rat left ventricle.
American journal of physiology. Regulatory, integrative and comparative physiology 20020501
-
Acute effects of vascular modifying agents in solid tumors assessed by noninvasive laser Doppler flowmetry and near infrared spectroscopy.
Neoplasia (New York, N.Y.) 20020501
-
Effects of antihypertensive drugs on ultrasound production and cardiovascular responses in 15-day-old rats.
Behavioural brain research 20020401
-
Relaxing effect of CEDO 8956 and hydralazine HCl in cultured smooth muscle cells versus pericytes: a preliminary study.
Klinische Monatsblatter fur Augenheilkunde 20020401
-
Vesicular glutamate transporter DNPI/VGLUT2 is expressed by both C1 adrenergic and nonaminergic presympathetic vasomotor neurons of the rat medulla.
The Journal of comparative neurology 20020312
-
Fosinopril improves left ventricular diastolic function in young mildly hypertensive patients without hypertrophy.
Cardiovascular drugs and therapy 20020301
-
Important role of Rho-kinase in the pathogenesis of cardiovascular inflammation and remodeling induced by long-term blockade of nitric oxide synthesis in rats.
Hypertension (Dallas, Tex. : 1979) 20020201
-
Effects of dihydropyridine-type Ca2+ antagonists on the renal arterial tree in spontaneously hypertensive rats.
Journal of cardiovascular pharmacology 20020101
-
Management of heart failure in the elderly.
Heart failure reviews 20020101
-
L-arginine augments cardiac vagal control in healthy human subjects.
Hypertension (Dallas, Tex. : 1979) 20020101
-
The renin-angiotensin and adrenergic nervous system in cardiac hypertrophy in fructose-fed rats.
American journal of hypertension 20020101
-
Nifedipine or hydralazine as a first-line agent to control hypertension in severe preeclampsia.
Acta obstetricia et gynecologica Scandinavica 20020101
-
Neuroprotective effect of treatment with calcium antagonists on hypertensive retina.
Clinical and experimental hypertension (New York, N.Y. : 1993) 20020101
-
Quantitative image analysis of choroid and retinal vasculature in SHR: a model of cerebrovascular hypertensive changes?
Clinical and experimental hypertension (New York, N.Y. : 1993) 20020101
-
Congestive heart failure: what should be the initial therapy and why?
American journal of cardiovascular drugs : drugs, devices, and other interventions 20020101
-
The direct effect of insulin on barosensitive neurones in the nucleus tractus solitarii of rats.
Neuroreport 20011204
-
Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure.
Circulation 20011120
-
Mechanisms of hydralazine induced vasodilation in rabbit aorta and pulmonary artery.
British journal of pharmacology 20011001
-
Changes of retinal neurons and glial fibrillary acid protein immunoreactive astrocytes in spontaneously hypertensive rats.
Journal of hypertension 20011001
-
The effect of vasodilators on aspirin-induced antagonism of t-PA thrombolysis.
Neurological research 20011001
-
Spinal nicotinic receptor activity in a genetic model of hypertension.
Clinical and experimental hypertension (New York, N.Y. : 1993) 20011001
-
Antihypertensive drugs induce structural remodeling of the penile vasculature.
The Journal of urology 20010801
-
Persistent cardiovascular effects of chronic renin-angiotensin system inhibition following withdrawal in adult spontaneously hypertensive rats.
Journal of hypertension 20010801
-
Influence of treatment with Ca(2+) antagonists on cerebral vasculature of spontaneously hypertensive rats.
Mechanisms of ageing and development 20010601
-
Left ventricular diastolic heart failure with normal left ventricular systolic function in older persons.
The Journal of laboratory and clinical medicine 20010501
-
Tailored treatments.
Trends in pharmacological sciences 20010501
-
Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice.
The Journal of clinical investigation 20010415
-
Photodynamic therapy with hypericin in a mouse P388 tumor model: vascular effects determine the efficacy.
International journal of oncology 20010401
-
AT1 receptor antagonist combats oxidative stress and restores nitric oxide signaling in the SHR.
Kidney international 20010401
-
Temporary treatment of prepubescent rats with angiotensin inhibitors suppresses the development of hypertensive nephrosclerosis.
Journal of the American Society of Nephrology : JASN 20010401
-
Oxytocin antagonist disrupts hypotension-evoked renin secretion and other responses in conscious rats.
American journal of physiology. Regulatory, integrative and comparative physiology 20010301
-
Influence of hydralazine administration on oxygenation in spontaneous and transplanted tumor models.
International journal of radiation oncology, biology, physics 20010301
-
L-Arginine improves endothelial function in renal artery of hypertensive Dahl rats.
Journal of hypertension 20010301
-
The influence of chronic antihypertensive treatment on the central pressor response in SHR.
Hypertension research : official journal of the Japanese Society of Hypertension 20010301
-
The generalizability of trial data; a comparison of beta-blocker trial participants with a prospective cohort of women taking beta-blockers in pregnancy.
European journal of obstetrics, gynecology, and reproductive biology 20010201
-
Left ventricle and arteries: structure, function, hormones, and disease.
Hypertension (Dallas, Tex. : 1979) 20010201
-
Influence of metabolic activation on the induction of micronuclei by antihypertensive drugs in L929 cells.
Archives of toxicology 20010201
-
Occurrence and distribution of atrial natriuretic peptide-containing cells in the left ventricle of hypertensive rats. Effect of antihypertensive treatment.
Cell and tissue research 20010101
-
Factor analysis, including antihypertensive medication, of the outcome of pregnancy in pregnancy-associated hypertension.
Kidney & blood pressure research 20010101
-
Antihypertensive treatment decreased serum leptin levels in severe preeclampsia during pregnancy.
Annals of nutrition & metabolism 20010101
-
Lisinopril reduces left ventricular hypertrophy and cardiac polyamine concentrations without a reduction in left ventricular wall stress in transgenic Tsukuba hypertensive mice.
Hypertension research : official journal of the Japanese Society of Hypertension 20001101
-
Nephroprotective effect of treatment with calcium channel blockers in spontaneously hypertensive rats.
The Journal of pharmacology and experimental therapeutics 20000901
-
Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies.
Arthritis and rheumatism 20000201
-
The antihypertensive hydralazine is an efficient scavenger of acrolein.
Redox report : communications in free radical research 20000101
-
Ventricular adrenomedullin levels correlate with the extent of cardiac hypertrophy in rats.
Hypertension (Dallas, Tex. : 1979) 19990501
-
Urocortin and inflammation: confounding effects of hypotension on measures of inflammation.
Neuroimmunomodulation 19990101
-
Dissociation of blood pressure reduction from end-organ damage in TGR(mREN2)27 transgenic hypertensive rats.
Journal of hypertension 19981201
-
The effects of pentobarbital on blood-brain barrier disruption caused by intracarotid injection of hyperosmolar mannitol in rats.
Anesthesia and analgesia 19980601
-
Regulation of glomerular TGF-beta expression in the contralateral kidney of two-kidney, one-clip hypertensive rats.
Journal of the American Society of Nephrology : JASN 19980501
-
Investigation of the inhibitory effect of N(G)-nitro-L-arginine methyl ester on the antihypertensive effect of the angiotensin AT1 receptor antagonist, GR138950.
British journal of pharmacology 19971201
-
Hydralazine inhibits human peritoneal mesothelial cell proliferation and collagen synthesis.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 19961101
-
Early genes induction in spontaneously hypertensive rats left ventricle with angiotensin-converting enzyme inhibitors but not hydralazine.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 19951201
-
Effect of beraprost sodium, a stable prostacyclin analogue, on pulmonary thromboembolism in mice.
Thrombosis research 19950115
-
Angiotensin II maintains, but does not mediate, isoproterenol-induced cardiac hypertrophy in rats.
The American journal of physiology 19941001
-
Management of eclampsia.
Seminars in perinatology 19940401
-
Hydralazine predisposes to acute cutaneous vasculitis following urography with iopamidol.
The British journal of dermatology 19930701
-
Alteration of cardiac collagen phenotypes in hypertensive hypertrophy: role of blood pressure.
Journal of molecular and cellular cardiology 19930201
-
Role of cardiac angiotensin II in isoproterenol-induced left ventricular hypertrophy.
Hypertension (Dallas, Tex. : 1979) 19920601
-
Myocardial ischemia during vasodilator therapy in a canine model of pulmonary hypertension and coronary insufficiency.
Anesthesiology 19920501
-
Action of hydrazine drugs in tumor-free and 1,2-dimethylhydrazine-treated male rats.
Oncology research 19920101
-
A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure.
The New England journal of medicine 19910801
-
Renal arteriolar diameters in spontaneously hypertensive rats. Vascular cast study.
Hypertension (Dallas, Tex. : 1979) 19910701
-
Effects of hydralazine and increased cardiac output on recombinant tissue plasminogen activator-induced thrombolysis in canine pulmonary embolism.
Chest 19910301
-
Cocaine intoxication associated with abruptio placentae.
Journal of the National Medical Association 19910301
-
Cardiotoxicity of hydralazine and minoxidil in the rat. Influence of age.
Research communications in chemical pathology and pharmacology 19910201
-
Hemodynamic effects of adenosine agonists in the conscious spontaneously hypertensive rat.
The Journal of pharmacology and experimental therapeutics 19900901
-
Acute cocaine toxicity: antagonism by agents interacting with adrenoceptors.
Pharmacology, biochemistry, and behavior 19900601
-
Changes of atrial natriuretic peptide and its messenger RNA with development and regression of cardiac hypertrophy in renovascular hypertensive rats.
Circulation research 19900101
-
Hydralazine-induced cholestatic jaundice following liver transplantation.
Transplantation 19890101
-
Antihypertensive effect of felodipine or hydralazine when added to beta-blocker therapy.
Journal of cardiovascular pharmacology 19880701
-
Additive effects of dihydralazine during enflurane or isoflurane hypotensive anaesthesia for spinal fusion.
Canadian journal of anaesthesia = Journal canadien d'anesthesie 19880501
-
[Effects of cadralazine on the respiration, circulation, kidney, autonomic nervous system, digestive system, blood and so on].
Nihon yakurigaku zasshi. Folia pharmacologica Japonica 19880401
-
Comparative study on the short-term effects of angiotensin converting enzyme inhibitors (Lopirin, SQUIBB and Tensiomin), and dihydralazine in chronic cardiac failure.
Acta physiologica Hungarica 19880101
-
Sympathetic activity in idiopathic dilated cardiomyopathy. Influence of captopril and hydralazine.
Cardiovascular drugs and therapy 19870801
-
Reversal by hypothermia of vasodilator-induced tachycardia in anesthetized rats.
Archives internationales de pharmacodynamie et de therapie 19870801
-
Vasodilators and regression of left ventricular hypertrophy. Hydralazine versus prazosin in hypertensive humans.
The American journal of medicine 19870501
-
Influence of blood pressure on development of aortic medial smooth muscle hypertrophy in spontaneously hypertensive rats.
Hypertension (Dallas, Tex. : 1979) 19870201
-
Effect of isoprenaline on tissue elastin content and serum elastolytic activity in normal and hydrazinophthalazine-treated rats.
Biomedica biochimica acta 19870101
-
Hemodynamic effects of hydralazine in infants with idiopathic dilated cardiomyopathy and congestive heart failure.
American heart journal 19870101
-
Antihypertensive drugs inhibit hypertension-associated aortic DNA synthesis in the rat.
Hypertension (Dallas, Tex. : 1979) 19861201
-
Control of hypertension following carotid endarterectomy.
The American surgeon 19861101
-
Effects of captopril and a combination of hydralazine and isosorbide dinitrate on myocardial sympathetic tone in patients with severe congestive heart failure.
British heart journal 19860801
-
Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat.
The Journal of clinical investigation 19860601
-
Comparative study of endralazine and hydralazine for the treatment of hypertension uncontrolled by a beta-blocker and diuretic.
Current medical research and opinion 19860101
-
A comparison of the acute hemodynamic effects of prostacyclin and hydralazine in primary pulmonary hypertension.
American heart journal 19851201
-
Vasodilator effect of indapamide in dog mesenteric vasculature.
Japanese journal of pharmacology 19851101
-
Effects of hydralazine on pressure-volume and stress-volume relations in congestive heart failure secondary to idiopathic dilated cardiomyopathy.
The American journal of cardiology 19851001
-
Therapeutic implications of hypertension-induced glomerular injury. Comparison of enalapril and a combination of hydralazine, reserpine, and hydrochlorothiazide in an experimental model.
The American journal of medicine 19850927
-
Acute hemodynamic effects of pinacidil and hydralazine in essential hypertension.
Clinical pharmacology and therapeutics 19850301
-
Suppression of ventricular arrhythmias after coronary artery ligation by pinacidil, a vasodilator drug.
Journal of cardiovascular pharmacology 19850101
-
Effect of hydralazine on serial measurements of exchangeable sodium and blood pressure in spontaneously hypertensive rats.
Clinical and experimental hypertension. Part A, Theory and practice 19850101
-
Effects of felodipine on resistance and capacitance vessels in patients with essential hypertension.
Drugs 19850101
-
[Liver lesions induced by dihydralazine and propranolol].
Zentralblatt fur allgemeine Pathologie u. pathologische Anatomie 19850101
-
Hydralazine-induced cholangitis.
Gastroenterology 19841101
-
Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
Drugs 19840101
-
Comparative actions of hydralazine, nifedipine and amrinone in primary pulmonary hypertension.
The American journal of cardiology 19831101
-
Simultaneous treatment of Raynaud's phenomenon and orthostatic hypotension.
The American journal of medicine 19830901
-
Effects of hydralazine on cardiopulmonary function in canine low-pressure pulmonary edema.
Anesthesiology 19830901
-
Treatment of hypertension associated with head injury.
Journal of neurosurgery 19830901
-
Hemodynamic responses to combined therapy with captopril and hydralazine in patients with severe heart failure.
Journal of the American College of Cardiology 19830801
-
Some wrong-way chemical changes during antihypertensive treatment: comparison of indapamide and related agents.
American heart journal 19830701
-
Vasodilators in the treatment of hypertension.
Comprehensive therapy 19821101
-
Effects of hydralazine on coronary blood flow and myocardial energetics in congestive heart failure.
Circulation 19820301
-
Psychiatric side effects of antihypertensive drugs other than reserpine.
Journal of clinical psychopharmacology 19820201
-
Treatment of hypertensive emergencies of pregnancy.
Clinical pharmacy 19820101
-
A model for evaluation of postural hypotension induced by drugs in conscious restrained normotensive rats.
Journal of pharmacological methods 19820101
-
Acute vasodilator therapy increases renal clearance of digoxin in patients with congestive heart failure.
Circulation 19811101
-
Obstructive jaundice, pancytophenia and hydralazine.
Lancet (London, England) 19810530
-
Hydralazine-induced hepatitis.
Hepato-gastroenterology 19810201
-
Pre- and postsynaptic alpha-adrenergic effects of the antihypertensive drug budralazine.
Arzneimittel-Forschung 19810101
-
Studies in the rat on endralazine, a new antihypertensive drug structurally related to hydralazine.
Clinical and experimental pharmacology & physiology 19810101
-
Correlation between decreased heart rate and central inhibition of sympathetic discharge after prazosin administration in the spontaneously hypertensive rat.
Clinical and experimental hypertension 19810101
-
Effect of beta-receptor-blocking agents on cardiovascular structural changes in spontaneous and noradrenaline-induced hypertension in rats.
Clinical science (London, England : 1979) 19801201
-
Electrophysiologic properties of hydralazine in man.
Pacing and clinical electrophysiology : PACE 19800901
-
Prospective study of immune response to hydralazine and development of antideoxyribonucleoprotein in patients receiving hydralazine.
The American journal of medicine 19800901
-
[Hypotensive anaesthesia in the oto-rhino-laryngological surgery using nitroglycerine (author's transl)].
Der Anaesthesist 19800501
-
[Rare liver damage caused by an antihypertensive and anti-arrhythmic agents].
Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete 19800401
-
Immunological side-effects of antihypertensive drugs.
Acta medica Scandinavica. Supplementum 19790101
-
[Treatment of essential hypertension with a combination of propranolol, spironolactone-thiabutazide and dihydralazine (author's transl)].
Deutsche medizinische Wochenschrift (1946) 19781020
-
Effect of propranolol on sympathetic nervous activity in hydrallazine-treated hypertensive patients.
British journal of clinical pharmacology 19780901
-
Renal plasma flow and cardiac output during hydralazine and propranolol treatment in essential hypertension.
Scandinavian journal of clinical and laboratory investigation 19780401
-
Cardiovascular responses to mianserin hydrochloride: a comparison with tricyclic antidepressant drugs.
British journal of clinical pharmacology 19780101
-
Plasma renin concentration in essential hypertension during beta-adrenergic blockade and vasodilator therapy.
European journal of clinical pharmacology 19771014
-
Clinical consequences of polymorphic acetylation of basic drugs.
Clinical pharmacology and therapeutics 19770901
-
Hypotension and bradycardia following diazoxide and hydralazine therapy.
JAMA 19770606
-
Some side-effects of alpha-methyldopa.
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 19760410
-
Induction of antibodies to nuclear antigens in rabbits by immunization with hydralazine-human serum albumin conjugates.
The Journal of clinical investigation 19751001
-
Long-term treatment of severe hypertension with minoxidil, propranolol and furosemide.
Circulation 19751001
-
[Exotoxin-induced polyneuropathies].
Wiener medizinische Wochenschrift (1946) 19750425
-
Use of the sphygmomanometer ASE-1 for the indirect measurement of blood pressure in the rat.
Polish journal of pharmacology and pharmacy 19750101
-
Letter: Sexual dysfunction due to methyldopa.
British medical journal 19741012
-
Galactorrhea and Parkinson-like syndrome: an adverse effect of alpha-methyldopa.
Metabolism: clinical and experimental 19701201